title: Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1.
abstract: The main excitatory neurotransmitter in the brain, glutamate (Glu), activates not only receptor-channels, but also receptors coupled to G-protein called metabotropic Glu receptors (mGluRs). Eight genes coding for mGluRs have been characterized to date giving rise to even more proteins due to alternative splicing phenomena. Here we characterized a splice variant of mGluR5, called mGluR5b which contains a 32 amino acid fragment inserted in the cytoplasmic tail, 50 residues after the 7th transmembrane domain. mGluR5b mRNAs are present in different regions of the adult rat brain and are expressed at a higher level than mGluR5a mRNA. Functional analysis of mGluR5a and mGluR5b revealed that they share all the properties of mGluR1a, but not those of mGluR1b or 1c. Like mGluR1a, both mGluR5a and mGluR5b activate a rapid and transient current in Xenopus oocytes. When expressed in LLC-PK1 cells, they show the same subcellular distribution as mGluR1a, and stimulate both inositol phosphate (IP) and cAMP production. Moreover, cells expressing mGluR5a or mGluR5b, like those expressing mGluR1a have a higher basal PLC activity that is not inhibited by glutamate-pyruvate transaminase (GPT), suggesting that these receptors have an intrinsic activity. Interestingly, the pharmacological profiles of mGluR5a and b are identical, but different from that of mGluR1a. Most agonists, except glutamate, are more potent on mGluR5a/b than on mGluR1a. Interestingly, the mGluR1a antagonists MCPG and 4CPG have no effect on mGluR5a/b; 4C3HPG which is a full antagonist at mGluR1a is a partial agonist at mGluR5a/b. These results indicate that the long C-terminal intracellular domain present only in mGluR1a and mGluR5a/b, although not well conserved, is likely to be involved in the specific functional properties of these receptors. Although the ligand recognition sites of mGluR5a/b and mGluR1a are highly conserved, these receptors have different pharmacology.
authors.affiliation: Mécanismes Moléculaires des Communications Cellulaires UPR 9023, CNRS CCIPE, Montpellier, France.
authors.forename: C
authors.initials: C
authors.lastname: Joly
authors.forename: J
authors.initials: J
authors.lastname: Gomeza
authors.forename: I
authors.initials: I
authors.lastname: Brabet
authors.forename: K
authors.initials: K
authors.lastname: Curry
authors.forename: J
authors.initials: J
authors.lastname: Bockaert
authors.forename: J P
authors.initials: JP
authors.lastname: Pin
mesh_terms: D017398:Alternative Splicing; D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D001921:Brain / Q000378:metabolism; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism; D003515:Cycloleucine / Q000031:analogs & derivatives / Q000494:pharmacology; D017931:DNA Primers; D005260:Female; D015723:Gene Library; D014644:Genetic Variation; D018698:Glutamic Acid / Q000378:metabolism; D007051:Ibotenic Acid / Q000494:pharmacology; D017403:In Situ Hybridization; D007668:Kidney; D008969:Molecular Sequence Data; D009498:Neurotoxins / Q000494:pharmacology; D009865:Oocytes / Q000502:physiology; D016133:Polymerase Chain Reaction; D016548:Prosencephalon / Q000378:metabolism*; D016318:Quisqualic Acid / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D018094:Receptors, Metabotropic Glutamate / Q000096:biosynthesis* / Q000187:drug effects / Q000502:physiology; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism; D015183:Restriction Mapping; D013154:Spleen / Q000378:metabolism; D013552:Swine; D014162:Transfection; D014981:Xenopus
chemical_list: D017931:DNA Primers; D009498:Neurotoxins; D012333:RNA, Messenger; D018094:Receptors, Metabotropic Glutamate; D011994:Recombinant Proteins; D003515:Cycloleucine; C036361:1-amino-1,3-dicarboxycyclopentane; D007051:Ibotenic Acid; D018698:Glutamic Acid; D016318:Quisqualic Acid; D000242:Cyclic AMP